期刊
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 28, 期 12, 页码 2171-2174出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2018.05.016
关键词
Prodrug-type RNA; Disulfide-bond cleavage; Reducing environment; 2(,)-0-modified siRNA
资金
- Ministry of Education, Culture, Sports, Science, and Technology, Japan [15 K21517, 24790121]
Small interfering RNAs (siRNAs) are an active agent to induce gene silencing and they have been studied for becoming a biological and therapeutic tool. Various 2(,)-0-modified RNAs have been extensively studied to improve the nuclease resistance. However, the 2(,)-0-modified siRNA activities were often decreased by modification, since the bulky 2(,)-0-modifications inhibit to form a RNA-induced silencing complex (RISC). We developed novel prodrug-type 2(,)-0-methyldithiomethyl (MDTM) siRNA, which is converted into natural siRNA in an intracellular reducing environment. Prodrug-type 2(,)-0-MDTM siRNAs modified at the 5(,)-end side including 5(,)-end nucleotide and the seed region of the antisense strand exhibited much stronger gene silencing effect than non-prodrug-type 2(,)-0-methyl (2(,)-0-Me) siRNAs. Furthermore, the resistances for nuclease digestion of siRNAs were actually enhanced by 2(,)-0-MDTM modifications. Our results indicate that 2(,)-0-MDTM modifications improve the stability of siRNA in serum and they are able to be introduced at any positions of siRNA.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据